Abstract
The success of myoblast transfer therapy can be assessed in a variety of ways. However, from the point of view of the utilization of experimental models in the development of this form of therapy, the methods used to determine its success depend on the particular biological questions that are being addressed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
B.J. Cooper, N.J. Winand, H. Stedman, B.A. Valentine, E.P. Hoffman, L.M. Kunkel, M. Oronzi Scott, K.H. Fischbeck, J.N. Kornegay, R.J. Avery, J.R. Williams, R.D. Schmickel, and J.E. Sylvester, The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334: 154–156 (1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Cooper, B.J. (1990). The Role of the XMD Dog in the Assessment of Myoblast Transfer Therapy. In: Griggs, R.C., Karpati, G. (eds) Myoblast Transfer Therapy. Advances in Experimental Medicine and Biology, vol 280. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5865-7_32
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5865-7_32
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5867-1
Online ISBN: 978-1-4684-5865-7
eBook Packages: Springer Book Archive